"Designing Growth Strategies is in our DNA"
Meningitis is an inflammation of membranes called meninges surrounding the brain and spinal cord. Mby viral, bacterial, parasitic and fungal infections. Meningitis has emerged as an area of global concern owing to its potential for causing an epidemic and hence, there is active government support to eradicate meningitis by establishing sophisticated diagnostic centers and hospitals to treat patients.
The diagnosis of meningitis are performed using either rapid latex agglutination test or by using highly advanced equipment for PCR, immunoassays, and others.
To get information on various segments, share your queries with us
The global is estimated to register a higher CAGR during the forecast period owing to factors such as high prevalence of meningitis, rise in demand for rapid diagnosis by using innovative technologies, increase in number of diagnostic centers and active government support to control meningitis disease outbreaks. However, lack of is a major factor restraining the growth of global meningitis diagnostic testing market during the forecast period.
The major companies in the global meningitis diagnostic testing market report include Siemens Healthcare GmbH, BioFire Diagnostics, Thermo Fisher Scientific Inc., Luminex Corporation, IMMY, Bio-Rad Laboratories Inc., Seegene Inc., and other players.
By Test Type
By Causative Agents
By End User
· Diagnostic Centres
· North America (USA, Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico, Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
The global meningitis diagnostic testing market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America followed by Europe accounted for largest share of the global meningitis diagnostic testing market in 2018. Asia Pacific is projected to grow at a faster pace due to the increasing patient awareness and developing healthcare infrastructure. In Middle East & Africa, the meningitis diagnostic testing market is anticipated to have an exponential growth due to the outbreak of meningitis in Sub-Saharan Africa. According to the World Health Organisation (WHO), the prevalence of meningitis is highest in regions from Senegal to Ethiopia, with approximately 30,000 cases reported each year and is considered as the “meningitis belt” of sub-Saharan Africa. These trends are attributed to fuel the demand for meningitis diagnosis in these regions. In Latin America meningitis is considered as a serious health concern and the meningitis diagnostic testing market is expected to project a moderate growth during the forecast period.